Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Capital Expenditures (2016 - 2025)

Dare Bioscience's Capital Expenditures history spans 10 years, with the latest figure at $385278.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 21.38% year-over-year to $385278.0; the TTM value through Dec 2025 reached $385278.0, down 22.98%, while the annual FY2025 figure was $385278.0, 22.98% down from the prior year.
  • Capital Expenditures reached $385278.0 in Q4 2025 per DARE's latest filing, up from -$330196.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $607331.0 in Q4 2023 to a low of -$330196.0 in Q3 2025.
  • Average Capital Expenditures over 5 years is $106168.5, with a median of $22099.0 recorded in 2023.
  • Peak YoY movement for Capital Expenditures: soared 22418.76% in 2023, then plummeted 1377.55% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $14524.0 in 2021, then plummeted by 81.43% to $2697.0 in 2022, then skyrocketed by 22418.76% to $607331.0 in 2023, then decreased by 19.31% to $490030.0 in 2024, then fell by 21.38% to $385278.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Capital Expenditures are $385278.0 (Q4 2025), -$330196.0 (Q3 2025), and $172865.0 (Q2 2025).